FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Antibodies topics
Antibodies
Recombinant
Nucleic Acid
Nucleic Acids
Polypeptide
Therapeutics
Immunoglobulin
Immunoglobulins
Monoclonal
Radiation Therapy
Desmoplastic
Hypertension
Hypertensive
Immunotherapy
Photodynamic Therapy

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Antibodies patents



      
           
This page is updated frequently with new Antibodies-related patent applications. Subscribe to the Antibodies RSS feed to automatically get the update: related Antibodies RSS feeds. RSS updates for this page: Antibodies RSS RSS


Date/App# patent app List of recent Antibodies-related patents
09/25/14
20140289876
 Mice that make heavy chain antibodies patent thumbnailnew patent Mice that make heavy chain antibodies
Genetically modified non-human animals and methods and compositions for making and using them are provided, wherein the genetic modification comprises a deletion in an immunoglobulin constant region ch1 gene (optionally a deletion in a hinge region) of an igg, iga, igd, and/or ige, and wherein the mouse is capable of expressing a functional igm. Genetically modified mice are described, including mice having a functional igm gene and modified to have a deletion of a ch1 domain and a hinge region in a heavy chain constant domain that is not an igm, e.g., in an igg heavy chain constant domain.
09/25/14
20140288288
 Anti-cd19 antibodies with reduced immunogenicity patent thumbnailnew patent Anti-cd19 antibodies with reduced immunogenicity
Anti-cd19 b4 antibodies with modified variable regions are disclosed. The modified anti-cd19 variable region polypeptides have alterations to one or more framework regions or complementarity determining regions of the heavy chain variable region or light chain variable region, thereby to reduce a t-cell response..
09/25/14
20140288280
 Cysteine engineered antibodies and conjugates patent thumbnailnew patent Cysteine engineered antibodies and conjugates
Cysteine engineered antibodies comprising a free cysteine amino acid in the heavy chain or light chain are prepared by mutagenizing a nucleic acid sequence of a parent antibody and replacing one or more amino acid residues by cysteine to encode the cysteine engineered antibody; expressing the cysteine engineered antibody; and isolating the cysteine engineered antibody. Certain highly reactive cysteine engineered antibodies were identified by the pheselector assay.
09/25/14
20140288277
 Compositions and methods for comprising an rna-specific fab library patent thumbnailnew patent Compositions and methods for comprising an rna-specific fab library
Methods and compositions are provided for studying and targeting rna structures. In particular, antibodies and antibody fragments that contain an fab were produced.
09/25/14
20140288276
 Humanized anti-ccr2 antibodies and methods of use therefor patent thumbnailnew patent Humanized anti-ccr2 antibodies and methods of use therefor
The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) cc-chemokine receptor 2 (ccr2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian ccr2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods..
09/25/14
20140288275
 Novel heterodimeric proteins patent thumbnailnew patent Novel heterodimeric proteins
The invention provides novel heterodimeric proteins including heterodimeric antibodies.. .
09/25/14
20140288274
 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof patent thumbnailnew patent Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
The present invention relates to human monoclonal antibodies neutralizing vascular endothelial growth factor receptor and the use thereof. More specifically, relates to human scfv molecules neutralizing vascular endothelial growth factor receptor, and a composition for inhibiting angiogenesis and a composition for treating cancer, which contain the human scfv molecules.
09/25/14
20140288272
 Antibody purification and purity monitoring patent thumbnailnew patent Antibody purification and purity monitoring
Processes for producing and purifying recombinant proteins are disclosed. In particular, the present disclosure provides processes of producing and purifying multi-subunit proteins expressed in yeast or filamentous fungal cells.
09/25/14
20140287952
 Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigens patent thumbnailnew patent Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigens
Methods of identifying antigen-specific antibody-secreting and antibody-forming cells, such as antigen-specific b cells, and methods for cloning the antigen-specific antibody sequences of the antibody produced by these cells are provided. In particular, the methods include enriching b cells for antigen-specific b cells, culturing the antigen-specific b cells to generate clonal b cell populations, detecting clonal b cells that produce a single antigen-specific antibody, optionally screening the clonal b cell populations for functional activity, staining and sorting the cells to isolate the antigen-specific b cells, sequencing the nucleic acids encoding the antigen-specific antibody sequences, expressing the sequences to produce an antibody, isolating the antibody and screening the antibody for antigen recognition.
09/25/14
20140287951
 Detection of auto-antibodies to specific glycans as diagnostic tests for autoimmune diseases patent thumbnailnew patent Detection of auto-antibodies to specific glycans as diagnostic tests for autoimmune diseases
The invention provides uses, methods, and kits for diagnosing an autoimmune disease, particularly scleroderma and systemic lupus erythematosus, in a subject by detecting the presence of one or more antibodies that specifically bind to one or more glycans in a subject sample.. .
09/25/14
20140287476
new patent Vibrio cholerae 0139 conjugate vaccines
The disclosure pertains to conjugates of the capsular polysaccharide of vibrio cholerae o139, or a structurally and/or immunologically related oligo- or poly-saccharide, and a carrier. These conjugates are useful as pharmaceutical compositions and/or vaccines to induce serum antibodies which have bactericidal (vibriocidal) activity against v.
09/25/14
20140287459
new patent Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
Methods for producing heterologous proteins are disclosed. In particular, the present disclosure provides improved methods of producing desired proteins, including multi-subunit proteins such as antibodies, with a higher yield and improved purity.
09/25/14
20140287443
new patent Characterization of cho-mif gene and protein, and use thereof
The present invention is concerned with the specific and highly sensitive detection of specific cho-mif (macrophage migration inhibitory factor from chinese ovarian hamster cell line) complexes in the production of anti-mif antibodies. The present invention is further concerned with the provision of specific antibodies which can be used for a cho-mif detection method.
09/25/14
20140287441
new patent Immunoassay for cyclopropylindole based synthetic cannabinoids, metabolites and derivatives thereof
The invention relates to the detection and quantification of cyclopropylindole based synthetic cannabinoids ur-144 and xlr-11 by providing antibodies based on novel immunogens. These antibodies can be incorporated into methods and kits for the detection of ur-144, xlr-11 and their metabolites..
09/25/14
20140287428
new patent Method for detection of bacteria in milk
A method of detecting the presence of bacteria in milk is provided, wherein milk is contacted with a preparation which may comprise an effective amount of at least one type of antibodies, said antibodies being capable of specifically binding to bacteria to be detected; staining said antibodies, before or after said contacting, with a staining preparation, said staining preparation being selected so that the antibodies stained therewith exhibit a color change or a change in color concentration when in contact with said bacteria; and determining the concentration of stained antibodies bound to bacteria in said milk from the presence and/or the relative intensity of the color change caused by contacting said milk with said stained antibodies.. .
09/25/14
20140287402
new patent Method for screening cells
The invention relates to high throughput screening methods for identifying, isolating and retrieving cells secreting antibodies of interest, e.g., having functional activity and/or multi-antigen specificities. It further provides methods for the cloning of said antibodies vh/vl sequences and the generation of recombinant monoclonal antibodies derived thereof having the features of interest..
09/25/14
20140286999
new patent Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
The present invention refers to a pharmaceutical composition containing trifunctional bispecific and/or trispecific antibodies being capable of binding to a specific target antigen(s) for use in a method of immunizing mammals against diseases in which said target antigen(s) is (are) involved, and further to a pharmaceutical composition containing trifunctional bispecific and/or trispecific antibodies being capable of binding to (a) specific target antigen (s) which is (are) involved in a disease of a mammal, specifically a human.. .
09/25/14
20140286980
new patent Infectious clones of torque teno virus
The present invention is directed to novel nucleotide and amino acid sequences of torque teno virus (“ttv”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine ttv genotypes and isolates.
09/25/14
20140286976
new patent Chimeric human-llama antigens and methods of use
Provided are chimeric, camelid-human (e.g., llama-human) polypeptides comprising a first antigenic polypeptide portion and a second antigenic polypeptide portion wherein the first antigenic portion is a derived from a first portion of a camelid (e.g., llama) and the second antigenic portion is a human polypeptide homolog of a second portion of the camedid antigen. The chimeric polypeptides are useful inter alia for epitope mapping and generation of antibodies that bind to a desired region of human antigen..
09/25/14
20140286963
new patent Methods and compositions for neural disease immunotherapy
The invention provides antibodies to specific neural proteins and methods of using the same.. .
09/25/14
20140286960
new patent Staphlococcus aureus alpha-hemolysin antibodies
Compositions and methods for the treatment or prevention of staphyloccus aureus infection in a subject are provided. Antibody compositions comprising monoclonal antibodies to alpha-hemolysin protein are also provided.
09/25/14
20140286959
new patent Methods of treating inflammatory disorders using anti-m-csf antibodies
The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to a m-csf, preferably human m-csf, and that function to inhibit a m-csf. The invention also relates to human anti-m-csf antibodies and antigen-binding portions thereof.
09/25/14
20140286958
new patent Interleukin-31 monoclonal antibody
An isolated antibody that specifically binds to at least one of canine interleukin-31 (il-31) or feline il-31 is provided. Such antibodies can be in the form of diagnostic and/or veterinary compositions useful for treating a pruritic and/or allergic condition in dogs or cats..
09/25/14
20140286957
new patent Antibodies to cd1d
Isolated antibodies or antigen binding portions thereof that bind to cd1d. These antibodies and antigen binding portions thereof have application in treatment of conditions involving nkt cell effector function..
09/25/14
20140286956
new patent Modulating inflammasome activity and inflammation in the central nervous system
Compositions and methods for reducing inflammation in the central nervous system (cns) of a mammal that has been subjected to a stroke, traumatic injury to the cns such as traumatic brain injury (tbi), spinal cord injury (sci), or having an autoimmune or cns disease have been developed. The compositions and methods described herein include antibodies that specifically bind to at least one component (e.g., asc, nalp1) in a mammalian inflammasome (e.g., the nalp1 inflammasome) and have use as treatments for sci, tbi, stroke, and autoimmune and cns diseases in a mammal.
09/25/14
20140286953
new patent Hepcidin, hepcidin antagonists and methods of use
The invention relates to purified, correctly folded hepcidin, antibodies that bind hepcidin, and methods of making and using such materials. Also provide are methods of treated hepcidin-related disorders..
09/25/14
20140286950
new patent Use of anti-cd83 agonist antibodies for treating autoimmune diseases
This invention relates to compositions comprising anti-cd83 agonist antibodies and methods of treating autoimmune disorders (such as inflammatory bowel disease) with anti-cd83 agonist antibodies, as well as articles of manufacture comprising anti-cd83 agonist antibodies.. .
09/25/14
20140286946
new patent Method for preparing antibodies having improved properties
The present invention is directed to methods and compositions for the production of fc-containing polypeptides having improved properties.. .
09/25/14
20140286941
new patent Treatment of tnfalpha related disorders
Methods of treating tnfα-related disorders comprising administering tnfα inhibitors, including tnfα antibodies are described.. .
09/25/14
20140286940
new patent Treatment of tnfalpha related disorders
Methods of treating tnfα-related disorders comprising administering tnfα inhibitors, including tnfα antibodies are described.. .
09/25/14
20140286939
new patent Treatment of tnfalpha related disorders
Methods of treating tnfα-related disorders comprising administering tnfα inhibitors, including tnfα antibodies are described.. .
09/25/14
20140286937
new patent Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
We provide an antibody capable of binding to an intracellular prl-i or prl-3 polypeptide, in which the antibody is capable of binding to an epitope bound by antibody 269, antibody 223 or antibody 318. Such anti-prl antibodies may be capable of binding to intracellular prl-i or prl-3.
09/25/14
20140286936
new patent Anti-human cxcr4 antibodies
The present invention provides novel antibodies to human cxcr4 with high affinity to the target and the ability to act potently as antagonists. The antibodies disclosed herein bind to a diverse range of epitopes..
09/25/14
20140286934
new patent Humanized antibodies that bind to cd19 and their uses
The present invention relates to humanized antibodies or fragments thereof that bind to human cd19. More specifically, the present invention relates to a humanized antibody or fragment thereof that binds to human cd19 comprising a heavy chain cdr1 comprising the amino acid sequence of seq id no: 27, and/or a heavy chain cdr2 comprising the amino acid sequence of seq id no: 28, and/or a heavy chain cdr3 comprising the amino acid sequence of seq id no: 29; and/or comprising a light chain cdr1 comprising the amino acid sequence of seq id no: 30, and/or a light chain cdr2 comprising the amino acid sequence of seq id no: 31 and/or a light chain cdr3 comprising the amino acid sequence of seq id no: 32..
09/25/14
20140286930
new patent Treatment of mammalian physiological reaction of ige antibodies present in said mammal upon contact with the corresponding antigen
A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of ige antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of therapeutically effective amount of a neurotoxin (cnt) derived from clostridia sp.. .
09/25/14
20140286861
new patent Rs7 antibodies
This invention relates to monovalent and multivalent, monospecific binding proteins and to multivalent, multispecific binding proteins. One embodiment of these binding proteins has one or more binding sites where each binding site binds with a target antigen or an epitope on a target antigen.
09/25/14
20140286859
new patent Psma antibodies and uses thereof
The invention includes stable multimeric, particularly dimeric, forms of psma protein, compositions and kits containing dimeric psma protein as well as methods of producing, purifying and using these compositions. Such methods include methods for eliciting or enhancing an immune response to cells expressing psma, including methods of producing antibodies to dimeric psma, as well as methods of treating cancer, such as prostate cancer..


Popular terms: [SEARCH]

Antibodies topics: Antibodies, Recombinant, Nucleic Acid, Nucleic Acids, Polypeptide, Therapeutics, Immunoglobulin, Immunoglobulins, Monoclonal, Radiation Therapy, Desmoplastic, Hypertension, Hypertensive, Immunotherapy, Photodynamic Therapy

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Antibodies for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Antibodies with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.1873

4095

4 - 0 - 76